Q2PCF1 AF NFT

Pleiotropic drug resistance protein 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeih4ngdpyg6p35dl73hse3nteld6c66mg7khdxkwywpmw3haw76aey/metadata.json
IPFS of structure file: 
bafybeignh5enyeynr35nl3vboyj3zu22hqbwvfgeb6azvwr47ti3pnqvcm/AF-Q2PCF1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9931aC92C1f19DC0Af842b9E513171F8C449e45a
First NFT owner address (bech32): 
genesis1nyc6eykp7xwuptuy9w09zvt3lrzynez6a87uur
Current NFT ID #291052 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
291052
Accession (UniProt):
Q2PCF1
Name::
Pleiotropic drug resistance protein 2
Experimental Method:
Predicted structure
Sequence source:
NICOTIANA PLUMBAGINIFOLIA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2PCF1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2PCF1|PDR2_NICPL Pleiotropic drug resistance protein 2 OS=Nicotiana plumbaginifolia OX=4092 GN=PDR2 PE=2 SV=1 MEESFLGDELTRLRSNSRMSSWRSSQSIREVFGGSSDVFMKNYSTRWREMAEEEEKELKWAAIDRLPTYNRLRKGMMKEVMSNGRVVHHEVDMTKLGNQDKKVLMESILKVVEDDNEQFLRRLRNRTDRVGIEIPKIEVRFQNLSVGGDAYVGTRALPTLLNSTLNTIEAVLGLIHLSPSKKRVVKILEDVSGIIRPSRMTLLLGPPGSGKTTFLKALAGKSEKDLRVNGKITYCGHEFHEFVPQRTSAYISQHDLHHGEMTVRETLDFAGRCLGVGTRYDLLVELSRREKEAGIMPDPQIDAFMKATAIDGQETSLITDYVLKILGLDICADIMVGDDMRRGISGGQKKRVTTGEMLVGPAKAFFMDEISKGLDSSTTYQIVKFMRQMVHINDITMVISLLQPAPETFDLFDDVIVLSEGQIVYQGPRENVLEFFEYMGFRCPERKAIADFLLEVTSKKDQEQYWFRKSRPYVYISVPEFSESFNSFQIGEQIIEELTIPYDKYSVHRAALVKNKYGISSWELFKSCFTREWLLMKRSSFLYIFKTTQITIMATIALTVFLRTQMKAGTVKDSAKFWGALFFSLINVMFNGMQELAMTVFRLPVFFKQRNSLFYPAWAFALPIWVLKIPISLVESAIWIILTYYTIGFAPAASRFFKQLLAFIGVHQMALSLFRFIAAAGRTQVVANTLGTFTLLMVFILGGFIVSKDDIQDWMIWGYYLSPMMYGQNAIAINEFLDDRWSAPTNGSQPTVGKTLLHARGLFTTESWYWISIGALFGFSLLFNVLFIAALTFLNPIGDTKAVKVENGDKNNRRPQETAIVGDIQMAPTRSQANTSSVIPFPNNESRKGMILPFQPLSLAFNHVNYYVDMPAEMKTQGVEEERLQLLRDASGAFRPGILTALVGVSGAGKTTLMDVLAGRKTGGYIEGSINISGYPKNQTTFARVSGYCEQNDIHSPYVTVYESLLYSAWLRLASDVKTETRKMFVEEVMELVELKLLRNALVGLPGVDGLSTEQRKRLTTAVELVANPSIIFMDEPTSGLDARAAAIVMRTVRKTVDTGRTVVCTIHQPSIDIFEAFDELLLMKIGGQVIYAGPLGHRSHKLVEYFETIPGVPKIRESDNPATWMLDVSSSSMEAQLVVDFAEVYANSNLYQRNQLLIKELSTPATCSKDLYFPTQYSQSFITQCKACFWKQHWSYWRNSQYNAIRFFMTVIIGILFGVIFWNKGNQIHRQQDLLNLLGATYAAVMFLGATNASAVQSVVAIERTVFYRERAAGMYSELPYAFAQVAIETIYVAIQTFVYSLLLFSMIGYQWTAVKFFYFYYFIFMCFTYFSMYGMMVVALTPGYQIAAIVMSFFLSFWNLFSGFLIPRPLIPVWWRWYYWASPVAWTIYGIFASQVGDRTDELELTGETEKIQVNEFLKEYLGYDHDFLLVVVFAHVGWVLLFFFVFAYGIKFLNYQKR